发明名称 Cochleate compositions directed against expression of proteins
摘要 Disclosed herein are novel siRNA-cochleate and morpholino-cochleate compositions. Also disclosed are methods of making and using siRNA-cochleate and morpholino-cochleate compositions.
申请公布号 US9259392(B2) 申请公布日期 2016.02.16
申请号 US201314038810 申请日期 2013.09.27
申请人 RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 发明人 Gould-Fogerite Susan;Mannino Raphael J.;Ahl Patrick;Shang Gaofeng;Chen Zi Wei;Krause-Elsmore Sara L.
分类号 C12N15/11;A61K9/127;A61K31/7048;C12N15/113;A61K38/00 主分类号 C12N15/11
代理机构 MH2 Technology Law Group, LLP 代理人 MH2 Technology Law Group, LLP
主权项 1. An siRNA-cochleate composition comprising: a cochleate; and an siRNA associated with the cochleate, wherein the cochleate comprises a negatively charged lipid component and a multivalent cation component, wherein the siRNA is complexed with a transfection agent prior to contacting a liposome, wherein the transfection agent is a cationic transfection agent.
地址 New Brunswick NJ US